51. Impaired renal function but high sustained virological response (SVR) rates in hepatitis C virus (HCV) elderly treated with direct-acting antivirals (DAA): A report from the Lombardy Network. Issue 1 (February 2018) Authors: D'Ambrosio, R.; Pasulo, L.; Aghemo, A.; Puoti, M.; Zaltron, S.; Maggiolo, F.; Rizzardini, G.; Fargion, S.; Sacchi, P.; Gulminetti, R.; Zuin, M.; Quirino, T.; Rumi, M.G.; Pan, A.; Grossi, P.; Rossini, A.; Corbellini, A.; Foppa, C. Uberti; Colli, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. Improvement of clinical parameters in HDV patients with advanced compensated cirrhosis treated with Bulevirtide monotherapy for 48 weeks. (March 2023) Authors: Degasperi, E.; Anolli, M.P.; Renteria, S.C. Uceda; Sambarino, D.; Borghi, M.; Perbellini, R.; Facchetti, F.; Loglio, A.; Monico, Sara; Fraquelli, M.; Costantino, A.; Ceriotti, F.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. Incidence and outcome of portal vein thrombosis in 817 HBV and HCV cirrhotic patients under antiviral treatment: a single center longitudinal study. (February 2019) Authors: Tosetti, G.; Loglio, A.; Degasperi, E.; D'Ambrosio, R.; Viganò, M.; Iavarone, M.; Borghi, M.; Soffredini, R.; Facchetti, F.; Rumi, M.G.; Primignani, M.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. Incidence and outcome of portal vein thrombosis in HCV cirrhotic patients treated with direct-acting antivirals: A single-center prospective 3-year study. Issue 1 (February 2018) Authors: Degasperi, E.; Tosetti, G.; D'Ambrosio, R.; Aghemo, A.; Borghi, M.; Soffredini, R.; Primignani, M.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
55. Incidence and predictors of de novo hepatocellular carcinoma in HCV cirrhotic patients treated with direct-acting antivirals: A single-center prospective 3-year study. Issue 1 (February 2018) Authors: D'Ambrosio, R.; Degasperi, E.; Iavarone, M.; Sangiovanni, A.; Aghemo, A.; Soffredini, R.; Borghi, M.; Perbellini, R.; Lunghi, G.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
56. Incidence and prognostic factors of "de novo" development/worsening of esophageal varices in HCV-related chronic advanced liver disease after sustained virologic response achieved by direct oral antiviral agents. (February 2019) Authors: Tosetti, G.; Soru, P.; La Mura, V.; Degasperi, E.; D'Ambrosio, R.; Arsiè, E.; Borghi, M.; Soffredini, R.; Primignani, M.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
57. Incidence and risk factors of esophagogastric varices bleeding in cirrhotic patients with advanced hepatocellular carcinoma treated with lenvatinib. (March 2023) Authors: Iavarone, M.; Alimenti, E.; Tada, T.; Shimose, S.; Suda, G.; Yoo, C.; Soldà, C.; Piscaglia, F.; Casadei-Gardini, A.; Marra, F.; Vivaldi, C.; Conti, F.; Schirripa, M.; Iwamoto, H.; Sho, T.; Lee, So Heun; Rizzato, M.D.; Tonnini, M.; Rimini, M.; Campani, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
58. Incidence of liver-related events in 647 HCV cirrhotics treated with DAA: A 5-year single center study. (March 2021) Authors: D'Ambrosio, R.; Degasperi, E.; Anolli, M.P.; Fanetti, I.; Borghi, M.; Soffredini, R.; Iavarone, M.; Tosetti, G.; Perbellini, R.; Sangiovanni, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
59. Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma. (15th February 2015) Authors: Viganò, M.; Grossi, G.; Borsotti, E.; Cappelletti, M.; Goldaniga, M.; Farina, L.; Rumi, M.; Corradini, P.; Baldini, L.; Colombo, M.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
60. Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection? Authors' reply. Issue 10 (May 2014) Authors: Galmozzi, E.; Viganò, M.; Lampertico, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 10(2014) Page Start: 1251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗